Antipsychotics academic detailing

Slides:



Advertisements
Similar presentations
Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective Clive Ballard Professor of Age Related.
Advertisements

New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Powys-wide, Primary care audit Rhiannon Davies, Powys tHB Medicines Management Team Prescribing of Antipsychotic Medication in Patients with Dementia.
 incidence  characteristics  causes?  treatments?
The Right Prescription A Call to Action for junior doctors on the use of antipsychotic drugs for people with dementia.
Treatment Options for Dementia Deb Bynum, MD Division of Geriatric Medicine University of North Carolina.
Criteria for Psychiatric Symptoms in Alzheimer’s Disease Clinical Trials Jeffrey L. Cummings, M.D. Alzheimer’s Disease Center UCLA School of Medicine FDA.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 31 Antipsychotic Agents and Their Use in Schizophrenia.
Valproic Acid to Treat Agitation in Dementia By: Samia B.
Bipolar disorder (BD) is a psychological disorder that is characterized by episodes if depression alternating with episodes of mania. During a depressive.
M USIC THERAPY IN MODERATE AND SEVERE DEMENTIA OF A LZHEIMER ’ S TYPE : A CASE - CONTROL STUDY H.B. Svansdottir and J. Snaedal Presented by Justine Ho.
Antipsychotic Medications in the Primary Care Practice Angelo Potenciano, M.D.
1 Just The Facts Ma’am Dementia Care & Anti-Psychotics Just The Facts Ma’am December 17, 2012 Ronald A. Savrin, MD, MBA, FACS Medical Director, Ohio KePRO.
Best Practice Guide: Treatment and care for behavioural and psychological symptoms Clive Ballard, Anne Corbett, Alistair Burns Alzheimer’s Society UK.
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
Agranulocytosis A acute condition involving a severe and dangerous leukopenia. The absence of Granulocytes.
THE EFFECT OF EXERCISE ON BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA: A REVIEW OF THE LITERATURE Dr. Ingela Thuné-Boyle Prof. Steve Iliffe UCL,
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
WHAT IS THE EVIDENCE ON EFFECTIVENESS OF ANTIPSYCHOTICS IN PERSONS WITH DEMENTIA? 1.
Quality in Practice (Winterbourne) Event 20/09/2013 Dignity in Dementia Care Denise J Mackey Derbyshire County Council Learning and Development Adult Care.
Treatment of Schizophrenia THE DEBATE OF THE YEAR! EFFICACY vs. TOLERABILITY: WHICH TRUMPS? POINT- COUNTERPOINT.
Further knowledge in dementia part 2. Welcome Introductions Group Agreement What will be achieved from this session? South West Dementia PartnershipFurther.
Use of Antipsychotic Drugs in Dementia Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology Chief, Division of Geriatric.
Issues to be addressed Is BPSD one entity? Is BPSD part of the diagnosis of dementia? Are BPSD symptoms which cut across diagnoses? Which syndromes have.
Behavior Disorders of Dementia: Recognition and Treatment Arpana Tewari, MD. AAFP Lecture 08/02/06.
Prescribing in Dementia. Plan What to prescribe? When to prescribe? How to review? Who to review?
Mental Health Nursing: Pharmacology: Antipsychotic Medications C. Calzolari 2016.
NICE guidance Generalised Anxiety Disorder Alex Hill.
Music therapy in moderate and severe dementia of Alzheimer’s type: a case-control study H.B. Svansdottir and J. Snaedal Geriatric Department, Landspitali.
Antipsychotic use in patients with dementia – How are we doing? Project Team Dr Seema Gupta, Consultant OPMH YGC, Audit Lead Elizabeth Bond, MH pharmacist.
Management of Geriatric Psychiatric Disorders Arash Mirabzadeh Psychiatrist University of Social Welfare and Rehabilitation Sciences.
Prescribing antipsychotics for children and adolescents
Pharmacological management of delirium
Dementia and Medication Considerations
A Welsh Overview of Pharmacy and Falls Prevention
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Depression in Older Adults with Dementia
Nuplazid™ - Pimavanserin
Agitation Medication  Side Effects Follow Up and Documentation
How To Design a Clinical Trial
Medication use in residential aged
Antipsychotic Agents and Their Use in Schizophrenia
Answers to Your Questions About Tardive Dyskinesia
One-Year Weight Gain While on Treatment with an Antipsychotic
Antipsychotic Prescribing
Neurocognitive Disorders
Expert Perspectives on New Treatment Options for Parkinson Disease Psychosis.
Martha Carvour, MD, PhD March 2, 2017
Antipsychotic-Induced Dysphagia
Drugs for Bipolar Disorder
Antipsychotic Agents and Their Use in Schizophrenia
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
EVALUATION OF THE STRUCTURED MEANINGFUL ACTIVITY PROGRAM FOR PERSONS WITH DEMENTIA (PWD) IN REN CI NURSING HOME ANGELIA LESTARI, NALINA KUMARI RESMI,
Athetosis, dystonia, tics
Managing Complex Hypertension: What Every Physician Should Know
RedUSe Final steering group report
Managing Hard-To-Treat Hypertension: What Every Physician Should Know
The Parkinson's Disease Psychosis Journal Club
Antipsychotics: chemistry and pharmacokinetics
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
The Research Question How and why do primary care physicians (PCPs) use medications including antipsychotics, as well as non-pharmacologic strategies,
Lurasidone Flavio Guzmán, MD.
Live From MDS New Developments in Parkinson's Disease Psychosis
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
1 in 100 people have had a schizophrenia episode. more than 2
Module 3 Indications for Antipsychotic Drugs
Risperidone – Binding Profile
The Research Question How and why do primary care physicians (PCPs) use medications including antipsychotics, as well as non-pharmacologic strategies,
Topic Discussion By Alexandria Brown
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Antipsychotics academic detailing Prepared for Testing RACF By i3soft, presented by Your Name

Medicines Used • Calming and sedative medicines can be used to treat Behavioural Symptoms of Dementia. • Example medicines include: Risperidone, Olanzapine, Quetiapine, Aripiprazole, Haloperidol, Paliperidone, Trifluoperazine and Ziprasidone • However, these medicines are known to have serious side effects, including stroke, falls, confusion, increased pneumonia, movement disorders (e.g. tremor) and increased chance of death. Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Key Points • Antipsychotics are effective in approximately one in five dementia patients for short-term management of significant agitation, aggression and psychosis. • Antipsychotics are less effective for some types of behavioural problems, for example, wandering, calling out, urinating in inappropriate places and hypersexuality Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Key Points • Non-pharmacologic therapy is equally or more effective than antipsychotics in many people with BPSD. • Antipsychotics may precipitate adverse effects, some of which mimic behavioural and psychological symptoms of dementia. • Serious adverse effects of antipsychotic agents include falls, increased mortality and increased risk of strokes. Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Key Points • Some people are more sensitive to the adverse effects of antipsychotic agents, such as those with Parkinson’s Disease, Lewy Body Dementia or cardiac damage. • Most people on long-term antipsychotics for BPSD can have their antipsychotics ceased, often with an improvement in symptoms. Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Strategies for reduction • People with dementia whose behavioural symptoms are unchanged or improving over weeks or months may bene t from a trial reduction. • People who no longer have troublesome BPSD may benefit from a trial reduction. • People who have been symptom or behaviour-free for three months or more should be considered for a trial reduction. • Cessation should be gradual, particularly if use has been long-term. • The Dementia Behaviour Management Advisory Service has developed a BPSD Guide, which is available as a phone or device application. Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Non-drug treatments Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Demographics Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

How do we compare? Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Which Medicines are used? Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016

Overview This presentation has: • Described common antipsychotic medicines • Given an overview of problems with the medicines • Explored some non-drug alternatives • Presented usage statistics at your facility Made with Prepared for Testing RACF by i3soft, presented by Mr Peter GEE. Created 6/12/2016